Extracorporeal photochemotherapy (extracorporeal photopheresis, ECP) is going to become
a new alternative in the treatment of cutaneous T cell lymphomas (CTCL), autoimmune …

Although extracorporeal photochemotherapy (ECP) is reported to be effective for a wide
variety of diseases, such as cutaneous T cell lymphoma, autoimmune diseases, organ graft …

Abstract Purpose of Review Extracorporeal photochemotherapy (photopheresis, ECP) is a
cell-based immunomodulatory treatment that separates leukocytes from peripheral blood …

Although significant advances have been made in the biologic understanding of graft-versus-
host disease (GVHD) and its treatment options, GVHD remains the single most challenging …

Background After the first investigational study on the use of extracorporeal photopheresis
for the treatment of cutaneous T‐cell lymphoma was published in 1983 with its subsequent …

Abstract Extracorporeal photochemotherapy (ECP; photopheresis), an immunomodulatory
therapy developed for cutaneous T‐cell lymphoma, has shown promise in treating chronic …

BACKGROUND AND OBJECTIVE: Extracorporeal photochemotherapy (ECP) is a
therapeutic approach based on the biological effects of ultraviolet light (UV)-A and psoralens …

Background: Extracorporeal photopheresis (ECP) has been successfully introduced for the
treatment of cutaneous T-cell lymphoma; however, the mechanism (s) of its action is (are) …

Extracorporeal photopheresis (ECP), a technique that exposes isolated white blood cells to
photoactivatable 8-methoxypsoralen and ultraviolet A radiation, is used clinically to treat …

Chronic graft-versus-host disease (GVHD) is the most important cause of late morbidity and
mortality in recipients of allogeneic blood and marrow transplantation. Despite increased …